{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:10:11Z","timestamp":1777641011952,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.antiviral.2022.105449","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T13:16:15Z","timestamp":1666012575000},"page":"105449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Thermodynamic and structural characterization of an optimized peptide-based inhibitor of the influenza polymerase PA-PB1 subunit interaction"],"prefix":"10.1016","volume":"208","author":[{"given":"Kate\u0159ina","family":"Radilov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e1clav","family":"Zima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Kr\u00e1\u013e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ale\u0161","family":"Machara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Majer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Hodek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u0159\u00ed","family":"Brynda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timotej","family":"Strme\u0148","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Konvalinka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9476-3409","authenticated-orcid":false,"given":"Milan","family":"Ko\u017e\u00ed\u0161ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2022.105449_bib1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.mjafi.2020.08.004","article-title":"Favipiravir: a new and emerging antiviral option in COVID-19","volume":"76","author":"Agrawal","year":"2020","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.antiviral.2022.105449_bib2","doi-asserted-by":"crossref","first-page":"14220","DOI":"10.1021\/ja206074j","article-title":"Assessing helical protein interfaces for inhibitor design","volume":"133","author":"Bullock","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2022.105449_bib3","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suite: programs for protein crystallography","volume":"50","author":"Collaborative Computational Project","year":"1994","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.antiviral.2022.105449_bib4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ejmech.2018.08.032","article-title":"Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction","volume":"157","author":"D'Agostino","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2022.105449_bib5","series-title":"The PyMOL Molecular Graphics System","author":"Delano","year":"2002"},{"key":"10.1016\/j.antiviral.2022.105449_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejmech.2017.06.015","article-title":"Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity","volume":"138","author":"Desantis","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2022.105449_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/518936","article-title":"Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide","volume":"196","author":"Deyde","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105449_bib8","first-page":"Doc02","article-title":"Prophylaxis and treatment of influenza: options, antiviral susceptibility, and existing recommendations","volume":"9","author":"Duwe","year":"2021","journal-title":"GMS Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105449_bib9","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.antiviral.2022.105449_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/anie.200390154","article-title":"Design and application of an alpha-helix-mimetic scaffold based on an oligoamide-foldamer strategy: antagonism of the Bak BH3\/Bcl-xL complex","volume":"42","author":"Ernst","year":"2003","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.antiviral.2022.105449_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.0.CO;2-E","article-title":"Enthalpy and heat capacity changes for the proton dissociation of various buffer components in 0.1 M potassium chloride","volume":"33","author":"Fukada","year":"1998","journal-title":"Proteins"},{"key":"10.1016\/j.antiviral.2022.105449_bib12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nature07120","article-title":"Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus","volume":"454","author":"He","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105449_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104971","article-title":"Structural characterization of the interaction between the C-terminal domain of the influenza polymerase PA subunit and an optimized small peptide inhibitor","volume":"185","author":"Hejdanek","year":"2021","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.antiviral.2022.105449_bib14","first-page":"67","article-title":"Antiviral therapy for the next influenza pandemic","volume":"4","author":"Hurt","year":"2019","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105449_bib15","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2022.105449_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104780","article-title":"Put a cork in it: plugging the M2 viral ion channel to sink influenza","volume":"178","author":"Jalily","year":"2020","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.antiviral.2022.105449_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.antiviral.2022.105449_bib18","series-title":"Profiling Drug Binding by Thermodynamics: Key to Understanding","first-page":"1","author":"Klebe","year":"2017"},{"key":"10.1016\/j.antiviral.2022.105449_bib19","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10822-015-9867-y","article-title":"Thermodynamics of protein-ligand interactions as a reference for computational analysis: how to assess accuracy, reliability and relevance of experimental data","volume":"29","author":"Krimmer","year":"2015","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.antiviral.2022.105449_bib20","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1107\/S0021889812011715","article-title":"XDSAPP: a graphical user interface for the convenient processing of diffraction data using XDS","volume":"45","author":"Krug","year":"2012","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.antiviral.2022.105449_bib21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0959-440X(00)00248-7","article-title":"Direct measurement of protein binding energetics by isothermal titration calorimetry","volume":"11","author":"Leavitt","year":"2001","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.antiviral.2022.105449_bib22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/QCO.0000000000000498","article-title":"Neuraminidase inhibitor resistance in influenza: a clinical perspective","volume":"31","author":"Lee","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105449_bib23","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/s41598-018-20772-9","article-title":"Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening","volume":"8","author":"Lo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2022.105449_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by Calpha geometry: phi,psi and Cbeta deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.antiviral.2022.105449_bib25","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1074\/jbc.M110.205534","article-title":"Disruption of the viral polymerase complex assembly as a novel approach to attenuate influenza A virus","volume":"286","author":"Manz","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2022.105449_bib26","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1021\/acs.jmedchem.5b01474","article-title":"Polymerase acidic protein-basic protein 1 (PA-PB1) protein-protein interaction as a target for next-generation anti-influenza therapeutics","volume":"59","author":"Massari","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2022.105449_bib27","first-page":"141","article-title":"The macromolecular crystallography beamlines at BESSY II of the Helmholtz-Zentrum Berlin: current status and perspectives","volume":"130","author":"Mueller","year":"2015","journal-title":"Eur. Phys. J. E"},{"key":"10.1016\/j.antiviral.2022.105449_bib28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.antiviral.2022.105449_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.antiviral.2019.03.003","article-title":"Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance","volume":"165","author":"Nannetti","year":"2019","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.antiviral.2022.105449_bib30","first-page":"9","article-title":"Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza","volume":"44","author":"Ng","year":"2019","journal-title":"P T"},{"key":"10.1016\/j.antiviral.2022.105449_bib31","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nature07225","article-title":"The structural basis for an essential subunit interaction in influenza virus RNA polymerase","volume":"454","author":"Obayashi","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105449_bib32","first-page":"3","article-title":"Applications of biocalorimetry: binding","author":"O\u2019 Brien","year":"2004","journal-title":"Stability and Enzyme Kinetics"},{"key":"10.1016\/j.antiviral.2022.105449_bib33","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1128\/JVI.75.17.8127-8136.2001","article-title":"Functional analysis of PA binding by influenza a virus PB1: effects on polymerase activity and viral infectivity","volume":"75","author":"Perez","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105449_bib34","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1039\/C4CC09441G","article-title":"Monitoring the cytosolic entry of cell-penetrating peptides using a pH-sensitive fluorophore","volume":"51","author":"Qian","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.antiviral.2022.105449_bib35","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/anie.201610888","article-title":"Enhancing the cell permeability and metabolic stability of peptidyl drugs by reversible bicyclization","volume":"56","author":"Qian","year":"2017","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.antiviral.2022.105449_bib36","series-title":"Schr\u00f6dinger Release 2022-3","year":"2021"},{"key":"10.1016\/j.antiviral.2022.105449_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107512","article-title":"Favipiravir, an anti-influenza drug against life-threatening RNA virus infections","volume":"209","author":"Shiraki","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2022.105449_bib38","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/med.21401","article-title":"The influenza virus polymerase complex: an update on its structure, functions, and significance for antiviral drug design","volume":"36","author":"Stevaert","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2022.105449_bib39","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1021\/acs.jmedchem.5b01935","article-title":"4,6-Diphenylpyridines as promising novel anti-influenza agents targeting the PA-PB1 protein-protein interaction: structure-activity relationships exploration with the aid of molecular modeling","volume":"59","author":"Trist","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2022.105449_bib40","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1107\/S0907444900013780","article-title":"An approach to multi-copy search in molecular replacement","volume":"56","author":"Vagin","year":"2000","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.antiviral.2022.105449_bib41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/bip.22623","article-title":"Recent progress in designing inhibitors that target the drug-resistant M2 proton channels from the influenza A viruses","volume":"104","author":"Wang","year":"2015","journal-title":"Biopolymers"},{"key":"10.1016\/j.antiviral.2022.105449_bib42","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1038\/s41598-017-10021-w","article-title":"Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction","volume":"7","author":"Watanabe","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2022.105449_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007517","article-title":"Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication","volume":"4","author":"Wunderlich","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2022.105449_bib44","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1128\/AAC.01419-10","article-title":"Identification of high-affinity PB1-derived peptides with enhanced affinity to the PA protein of influenza A virus polymerase","volume":"55","author":"Wunderlich","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2022.105449_bib45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2016.11.005","article-title":"Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface","volume":"137","author":"Yuan","year":"2017","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.antiviral.2022.105449_bib46","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1038\/s41598-018-22875-9","article-title":"Exploring ugi-azide four-component reaction products for broad-spectrum influenza antivirals with a high genetic barrier to drug resistance","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2022.105449_bib47","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.2174\/0929867325666180706112940","article-title":"Focusing on the influenza virus polymerase complex: recent progress in drug discovery and assay development","volume":"26","author":"Zhang","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2022.105449_bib48","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/acschembio.9b00552","article-title":"Discovery of influenza polymerase PA-PB1 interaction inhibitors using an in vitro split-luciferase complementation-based assay","volume":"15","author":"Zhang","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.antiviral.2022.105449_bib49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.drudis.2018.01.028","article-title":"Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics","volume":"23","author":"Zhou","year":"2018","journal-title":"Drug Discov. Today"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222002182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222002182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:36:35Z","timestamp":1759062995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354222002182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":49,"alternative-id":["S0166354222002182"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105449","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thermodynamic and structural characterization of an optimized peptide-based inhibitor of the influenza polymerase PA-PB1 subunit interaction","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105449"}}